Clinical Trial Update: Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT [Phase 3]

View source ↗

Summary

Phase 3 trial comparing surgery versus IMRT for early recurrent nasopharyngeal cancer, status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Recurrent Nasopharyngeal Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING